Skip to main content
Download PDF

The relationship between urinary albumin to creatinine ratio and all-cause mortality in the elderly population in the Chinese community: a 10-year follow-up study

BMC Nephrology volume 23, Article number: 16 (2022) Cite this article

Abstract

Background

In patients with diabetes and hypertension, proteinuria is independently associated with all-cause death. However, in the general population, urinary albumin to creatinine ratio (UACR) is less used to predict all-cause mortality. When the urinary albumin to creatinine ratio is within the normal range (UACR< 30 mg/g), the clinical relevance of an increased urinary albumin excretion rate is still debated. We studied the relationship between UACR and all-cause mortality in community populations, and compared UACR groups within the normal range.

Methods

The participants were the inhabitants from the Wanshoulu community in Beijing, China. The average age is 71.48 years, and the proportion of women is 60.1%. A total of 2148 people completed random urine samples to determine the urinary albumin to creatinine ratio (UACR). The subjects were divided into three groups according to UACR: Group 1 (UACR< 10 mg/g), Group 2 (10 mg/g < UACR< 30 mg/g), Group 3 (UACR> 30 mg/g). We used Kaplan-Meier survival analysis and Cox regression model to verify the relationship between UACR and all-cause mortality.

Results

At an average follow-up of 9.87 years (718,407.3 years), the total mortality rate were 183.4/1000. In the Cox proportional hazards model, after adjusting for possible confounders, those with normal high-value UACR (group 2) showed a higher all-cause mortality than those with normal low-value UACR (group 1) [hazard ratio (HR) 1.289, 95% confidence interval (CI) 1.002 ~ 1.659 for all-cause mortality]. Those with proteinuria (group 3) showed a higher all-cause mortality than those with normal low-value UACR (group 1) [hazard ratio (HR) 1.394, 95% confidence interval (CI) 1.020 ~ 1.905 for all-cause mortality].

Conclusion

Urinary albumin to creatinine ratio is an important risk factor for all-cause death in community population. Even if it is within the normal range (UACR< 30 mg/g), it occurs in people with high normal value (10 mg/g < UACR< 30 mg/g), the risk of all-cause death will also increase.

Peer Review reports

Background

With the acceleration of aging, when the age structure of the population becomes less young, tools for predicting the risk of all-cause mortality in the middle-aged and elderly have become more and more important in research, policy, and clinical practice [1,2,3,4]. Chronic kidney disease (CKD), defined as the presence of proteinuria and/or decreased renal function, is an /important risk factor for end-stage renal disease (ESKD), cardiovascular events and all-cause death [5]. In the general population, the association between proteinuria and all-cause death has received widespread attention. Albuminuria is highly prevalent among older adults, especially those with diabetes and hypertension [6,7,8,9]. It is associated with several chronic diseases [10]. However, its overall impact on the health of the elderly, as well as on all-cause mortality in the community, has not been studied in detail [11, 12]. The urinary albumin to creatinine ratio is a new and reliable method for monitoring the excretion of urine protein. The measurement of the urinary albumin to creatinine ratio can reliably reflect the amount of urine protein in 24 h. It is fast, simple and accurate. Urinary albumin to creatinine ratio has become a clinically qualitative and quantitative diagnostic index for proteinuria that can replace the traditional 24-h urine protein quantification [13, 14]. Studies have shown that high levels of urinary albumin excretion are associated with an increase in cardiovascular (CV) mortality, especially in patients with diabetes, and hypertension, as well as those with a history of cardiovascular disease, but there are few studies on the prediction of all-cause mortality in community populations [15,16,17,18,19]. In addition, in healthy people (UACR less than 30 mg/g), the urinary albumin to creatinine ratio as a risk indicator is controversial in predicting all-cause death in healthy people [20]. Their previous relationship and degree of association have not yet been specifically studied [2, 17, 21]. The few published studies on the urinary albumin to creatinine ratio and all-cause mortality are aimed at smaller populations, relying on retrospectively collected data, or the population is a special population with underlying diseases such as diabetes and hypertension [6,7,8,9, 22,23,24]. Therefore, in this study, we selected a relatively large cohort from the community population, followed up for 10 years, and studied the relationship between urinary albumin to creatinine ratio and all-cause mortality from multiple levels.

Methods

Subjects

Sampling and research methods were reported elsewhere [25, 26]. The previous study used a two-stage stratified clustering sampling method was used to conduct this population-based cross-sectional survey in participants living in Wanshoulu community, a representative urban residential area of Beijing. This study is based on a large-scale cohort study conducted by previous community populations. The average age is 71.48, the standard deviation is 6.77, and the proportion of women is 60.1%. Recruitment of the Wanshoulu community started in 2010, and a follow-up survey was conducted on the participants. Figure 1 shows the recruitment process of the study population.

Fig. 1
figure 1

Flow chart for the selection of study participants

Full size image

Data collection

Men and women filled out detailed baseline health and lifestyle questionnaires, and 2162 people participated in a health check conducted by trained nurses using standard procedures. At the time of consultation, a random urine sample was randomly selected to determine the urinary albumin to creatinine ratio (UACR). Information about drinking and smoking status, diabetes, hypertension, coronary heart disease history, NIHSS stroke scale, MMSE simple intelligence scale, ADL daily activity scale and other information were obtained from baseline health data and lifestyle questionnaires. The body mass index (BMI) is calculated by dividing the weight (Kg) by the square of the height (m), measuring the height with a stand-alone distance meter, and calculating the weight with an electronic scale. After the participant sat and rested for 5 min, the blood pressure was measured using a sphygmomanometer. The systolic and diastolic blood pressure were measured twice, and the average of the two was used for analysis. Hypertension is defined as high blood pressure or systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg as diagnosed by a doctor. Routine blood tests for fasting blood glucose, 2 h postprandial blood glucose, glycosylated hemoglobin, total serum cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides were measured on an automatic biochemical analyzer. All on-site urine samples were taken to determine the concentration of urinary albumin (mg/l) and the concentration of urinary creatinine (g/l), and calculate the UACR (mg/g). All biochemical analyses were performed in the Department of Biochemistry of the Chinese People’s Liberation Army General Hospital. Among the subjects, 1854 agreed to participate in the telephone follow-up or signed a written informed consent for community on-site follow-up, which constituted our study population. Regarding age and gender, there is no difference between responders and non-responders. This study was ethically approved by the Ethics Committee of the Chinese People’s Liberation Army General Hospital.

Study design

Our observations add to more and more evidence, and they challenge the idea that UACR< 30 mg/g means albumin excretion is “normal” [27]. Our research is more focused on “normal” urine albumin excretion, so we divide the urine protein-creatinine ratio into three groups, divide the range of proteinuria with a limit of 30 mg/g, and then divide the “normal” urinary albumin to creatinine ratio by 10 mg/g is divided into two groups. Analyze and compare the relationship between urinary albumin to creatinine ratio and all-cause death in the three groups [23, 28].

Endpoints

Endpoint death cases were defined as indicator events that occurred between baseline and follow-up until December 31, 2020. During the follow-up period, the main concern was all-cause death. In these analyses, all-cause death is defined as death from any cause, and the cause of death comes from the results of telephone calls or on-site follow-ups provided by family members. For some members of the group whose telephone numbers were lost to follow-up or whose home address was changed, our staff sought help from Wanshoulu community staff and police officers from the population management archives office of Wanshoulu police station.

Statistical analysis of data

All continuous data are expressed as mean ± standard deviation, while categorical data are expressed as absolute numbers and percentages (%). The Kolmogorov-Smirnoff test is used to check whether the data has a normal distribution. One-factor analysis of variance (ANOVA) test is used to analyze the baseline characteristics of the study populations. Post hoc multiple comparisons, the LSD test is used to assume that the variances are equal, and the Tamhane’s T2 test is used to assume that the variances are unequal. The chi-square test was used to compare the all-cause mortality of different groups after 10 years. The Kaplan-Meier method and log-rank test were used to compare cumulative probabilities. In the analysis of the Cox proportional hazards model, hazard ratio (HR) and 95% confidence interval (CI) were calculated after adjusting for age, gender, height, weight, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, triglycerides, blood creatinine, blood uric acid, history of coronary heart disease, history of diabetes, history of drinking. A multivariate logistic regression model was established to show the relationship between UACR and all-cause mortality. In the cox regression analysis, the Omnibus test is used to test the model coefficients, and the results are analyzed by one-minus survival analysis function, hazard function, and LML function. In all hypothesis tests, the risk of the first type of error is set a priori as P < 0.05. All statistical tests are two-sided, and the significance level is α = 0.05. Use SPSS software (version 26.0) for statistical analysis.

Results

Baseline characteristics

Among the 1854 study populations, there were 229 people with a UACR greater than 30 mg/g, and the prevalence of proteinuria was 12.3%; 1149 people with a UACR less than 10 mg/g, accounting for 62.0% of the total; 476 people with a UACR of 10 mg /g to 30 mg/g, accounting for 25.7% of the total number of people. Women accounted for 59.2% of the population. One-factor analysis of variance (ANOVA) test is used to analyze the baseline characteristics of the study populations. Post hoc multiple comparisons, the LSD test is used to assume that the variances are equal, and the Tamhane’s T2 test is used to assume that the variances are unequal. Table 1 shows the baseline characteristics of the study population by study group.

Table 1 Baseline characteristics of the study population (all men and women), by categories of UACR
Full size table

All-cause mortality

During the average follow-up period of 9.87 years (18,407.3 person-years of follow-up), 1854 subjects were followed up with 340 deaths (185 men and 155 women). The total population mortality, the rough all-cause mortality rates for males and females were 183.4/1000, 99.8/1000 and 83.6/1000, respectively. The mortality rate of men is slightly higher than that of women, which is consistent with the results of other studies in the region. Table 2 shows the comparison of all-cause mortality among the three groups according to the urinary albumin-creatinine ratio through the chi-square test.

Table 2 Chi-square test of all-cause mortality in different UACR groups
Full size table

As shown in Table 2, the mortality rate of people with proteinuria (Group 3) was 29.7%, which was higher than that of people without proteinuria. Among the two groups with normal urine protein, the mortality rate of the group with the higher UACR (Group 2) was 21.8%, which was higher than that of the group with the lowest UACR (Group 1). The higher the urinary albumin to creatinine ratio, the higher the mortality rate of the study population. Kaplan–Meier method and log-rank test were used to compare the cumulative probability. Figure 2 shows the Kaplan-Meier survival curves for different urine albumin-creatinine ratios. There is a significant dose-response relationship between UACR and all-cause mortality. The survival rate of the study population showed a significant downward trend with the increase of UACR (p < 0.001, tested by Log-Rank). It can also be seen from the Risk function graph that the greater the UACR, the greater the cumulative survival risk of the group.

Fig. 2
figure 2

Kaplan-Meier survival curves of different UACR groups in the study population (n = 1854) classified by the ratio of urine albumin to creatinine. a Survival analysis function; b Risk function. Group 1 (UACR< 10 mg/g), Group 2 (10 mg/g < UACR< 30 mg/g), Group 3 (UACR> 30 mg/g)

Full size image

Mortality risk

In order to study the effect of urine albumin-creatinine ratio on all-cause mortality, we performed Cox proportional hazards model fitting on the data. In addition to UACR, the following variables that can be used to explain all-cause deaths and differences in the group in the baseline analysis are included in the regression analysis: age, gender, height, weight, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, triglycerides, blood creatinine, blood uric acid, history of coronary heart disease, history of diabetes, history of drinking. After adjusting for the above variables that may affect survival, compared with Group 1 (UACR< 10 mg/g), Group 2 (10 mg/g < UACR< 30 mg/g) and Group 3 (UACR> 30 mg/g) have significant all-cause mortality increase. The Cox proportional hazard model was used to analyze multiple variables, which allows us to compare the effects of different variables on deaths from all causes. The results are summarized by the hazard ratio, by plotting the adjusted risk ratio as a function of UACR, and by plotting the causal specific cumulative correlation function of specific covariate values.

As shown in Fig. 3, from the survival analysis curve, risk curve and LML function, it can be seen that the survival rates of the three groups are significantly different (P < 0.001), and the greater the UACR, the greater the risk of death in the group. In the Cox proportional hazard model, taking group 1 (UACR< 10 mg/g) as a reference, the hazard ratio (HR value) of group 2 is 1.289 times that of group 1 (P = 0.048). The hazard ratio (HR value) of group 3 is 1.394 times that of group 1 (P = 0.037). From Table 3, the risk of all-cause death in patients with high UACR is lower than the risk of all-cause death in patients with low UACR. In each influencing factor of Cox proportional hazard model, UACR has a relatively large impact on all-cause death compared with other influencing factors.

Fig. 3
figure 3

Cox proportional hazards after adjusting age, gender, height, weight, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, triglycerides, blood creatinine, blood uric acid, history of coronary heart disease, history of diabetes, history of drinking. a Survival analysis function; b Hazard function; c LML function. Group 1 (UACR< 10 mg/g), Group 2 (10 mg/g < UACR< 30 mg/g), Group 3 (UACR> 30 mg/g)

Full size image
Table 3 Results of the multivariate Cox analyses on the risk of death by UACR levels
Full size table

Discussion

In this present study, after adjusting age, gender, height, weight, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, triglycerides, blood creatinine, blood uric acid, history of coronary heart disease, history of diabetes, history of drinking, taking group 1 as a reference, the hazard ratio of group 2 was 1.289 times that of group 1 (P = 0.048). The hazard ratio (HR value) of group 3 was 1.394 times that of group 1 (P = 0.037). The normal urine albumin-creatinine ratio recognized in our country is < 30 mg/g. Group 2 (10 mg/g < UACR< 30 mg/g) is a community population with a higher urine albumin-creatinine ratio within the normal range. Our results show that even if the urinary albumin and creatinine ratio is normal, if the UACR value is higher, it will still have a certain impact on all-cause death. This is the innovation of our research. Before our research, there have been reports at home and abroad that microalbuminuria (30 mg/g < UACR< 300 mg/g) can predict the risk of cardiovascular and all-cause death [22, 23, 29]. There is no doubt that UACR> 30 mg/g is proteinuria. Studies have divided proteinuria into microalbuminuria (30 mg/g < UACR< 300 mg/g) and massive proteinuria (UACR> 300 mg/g), and there is evidence that microalbuminuria can predict cardiovascular death and all-cause death [7, 30]. However, the research on the relationship between the normal high value of UACR (10 mg/g < UACR< 30 mg/g) and all-cause death is not detailed enough.

In 2020, another Chinese study showed that urinary albumin-creatinine ratio (UACR) within the normal range (less than 30 mg/g) would also increase the risk of cardiovascular disease. The optimal cut-off value of UACR for diagnosing diabetic left ventricular hypertrophy is 10 mg/g [27]. In our study to predict all-cause death, we used the same cut-off value, and the results were similar. In our study, the same cut-off value was used by us to predict all-cause death. The results are similar. The risk of all-cause death in the group with UACR< 10 mg/g is the lowest, and the results are statistically significant. The reason may be that kidney damage is a continuous process. In the process of the urinary albumin-creatinine ratio gradually increasing, the damage has already formed, which has a certain impact on the outcome of all-cause death. Therefore, the UACR range in the normal high value (10 mg/g < UACR< 30 mg/g) does not mean that it is healthy, and the damage has already occurred, which deserves more attention and research. A UK study in 2003 have shown that microalbuminuria (30 mg/g < UACR< 300 mg/g) can predict all-cause and cardiovascular disease mortality in men and women independently of other established cardiovascular risk factors. In all subjects Among them, compared with participants with normal albuminuria, individuals with microalbuminuria increased the risk of all-cause death by about 50%, and the risk of death from cardiovascular disease increased by about twice [17]. The results of our study are consistent with the study in the United Kingdom. There is a dose response relationship between the degree of proteinuria and the risk of death. However, the measurement unit range standard for the UACR used in the UK is different from that in China. In addition, unlike their research, our follow-up study time is longer, with an average of 9.87 years (18,407.3 person-years of follow-up). It makes our results more credible. Most importantly, the urine samples in their study were cryopreserved, and the measured urinary albumin to creatinine ratio may be inaccurate. Our data were all measured on-site during community surveys. A large-scale study in the Netherlands in 2002 pointed out that urine albumin excretion can predict cardiovascular and non-cardiovascular deaths in the general population [31]. The study included a population of 40,548 people with a large sample size. The results of the study showed that urinary albumin excretion increased twice, the relative risk of cardiovascular mortality was 1.29, and the relative risk of non-cardiovascular mortality was 1.12. The follow-up time of this study was only 3 years, so the mortality rate in the results was lower, and the relative risk of mortality was lower than the British study and our study.

In predicting the occurrence of cardiovascular disease, a 2005 study in the United States presented evidence that challenged the concept that UACR< 30 mg/g means normal [7]. This is the starting point for us to consider the relationship between normal UACR and all-cause death. The 2007 ESC-ESH Hypertension Management Guidelines stated: “In diabetic and non-diabetic hypertensive patients, microalbuminuria, even if it is below the currently considered threshold, has been proven to predict cardiovascular events.” [32] In the studies mentioned in the guidelines, the study population of Redon J et al. in 2002 and de Leeuw PW et al. in 2004 were mainly concentrated in the special hypertensive population [33, 34]. The study of Bigazzi R et al. in 1998, Jensen JS et al. in 2000, and Arnlöv J et al. in 2005 mainly explored the relationship between proteinuria and cardiovascular events [7, 16]. Although Gerstein HC et al. in 2001 and Jager A et al. in 1999 studied the relationship between proteinuria and death, their follow-up time was only 4.5 years and 5 years [6, 35].

Our study is the first time that groups within the range of normal urine albumin to creatinine ratio are used to predict all-cause mortality in community populations with 10-year follow-up. In terms of the pathological mechanism of the relationship between urine albumin-creatinine ratio and all-cause death, proteinuria may be an early sign of vascular endothelial dysfunction, which easily leads to the development of individual atherosclerosis [36]. Atherosclerosis and increased pulse pressure further damage vascular endothelial cells, forming a vicious circle, causing damage to the whole body. A study in Taiwan, China in 2018 also showed that there is a linear relationship between proteinuria and arterial stiffness in Chinese adults [37]. Arteriosclerosis is an important risk factor for cardiovascular and cerebrovascular diseases, which may be the pathological cause leading to all-cause death.

Compared with other studies, our study has a 10-year follow-up, a novel grouping standard, and enough community populations to prove the relationship between urine albumin-creatinine ratio and all-cause deaths in Chinese community populations. However, our study also has some shortcomings. First, most of our follow-ups are conducted through telephone consultation, and the degree of cooperation and response accuracy of the interviewed population may be biased. Secondly, in our study, 294 (13.7%) lost follow-up in 10 years. This tendency to attrition may have weakened our results. In the end, we had 1854 people included in the study, and the reduced sample size also reduced the robustness of our conclusions.

Previously, only in patients with hypertension and diabetes, doctors would pay attention to the patient’s urinary albumin to creatinine ratio, because many studies have shown that proteinuria is independently related to all-cause death. However, in the non-diabetic hypertensive population and the general community population, people pay insufficient attention to the ratio of urinary albumin to creatinine ratio. Through our research evidence, in clinical practice, doctors will pay more attention to the UACR indicator and have more choices in predicting the indicators and standards of death from all causes.

Availability of data and materials

The research data used to support the findings of this study are available from the corresponding authors upon request.

Abbreviations

UACR:

Urinary albumin to creatinine ratio

HR:

Hazard ratio

CI:

Confidence interval

CKD:

Chronic kidney disease

ESKD:

End-stage renal disease

CV:

Cardiovascular

NIHSS:

National institutes of health stroke scale

MMSE:

Minimum mental state examination

ADL:

Activity of daily living

CHD:

Coronary heart disease

References

  1. Li TC, Li CI, Liu CS, et al. Derivation and validation of 10-year all-cause and cardiovascular disease mortality prediction model for middle-aged and elderly community-dwelling adults in Taiwan. PLoS One. 2020;15(9):e0239063. https://doi.org/10.1371/journal.pone.0239063.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Astor BC, Hallan SI, Miller ER 3rd, et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167(10):1226–34. https://doi.org/10.1093/aje/kwn033.

    Article  PubMed  Google Scholar 

  3. Fan J, Yu C, Guo Y, et al. Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study. Lancet Public Health. 2020;5(12):e650–60. https://doi.org/10.1016/s2468-2667(20)30113-4.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ho JE, Lyass A, Courchesne P, et al. Protein biomarkers of cardiovascular disease and mortality in the community. J Am Heart Assoc. 2018;7(14). https://doi.org/10.1161/jaha.117.008108.

  5. Kon S, Konta T, Ichikawa K, et al. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the specific health check and guidance program in Japan. Clin Exp Nephrol. 2018;22(2):346–52. https://doi.org/10.1007/s10157-017-1455-0.

    Article  PubMed  Google Scholar 

  6. Jager A, Kostense PJ, Ruhé HG, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn study. Arterioscler Thromb Vasc Biol. 1999;19(3):617–24. https://doi.org/10.1161/01.atv.19.3.617.

    Article  CAS  PubMed  Google Scholar 

  7. Arnlöv J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham heart study. Circulation. 2005;112(7):969–75. https://doi.org/10.1161/circulationaha.105.538132.

    Article  PubMed  Google Scholar 

  8. Ninomiya T, Perkovic V, de Galan BE, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20(8):1813–21. https://doi.org/10.1681/asn.2008121270.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Duan JY, Duan GC, Wang CJ, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey. BMC Nephrol. 2020;21(1):115. https://doi.org/10.1186/s12882-020-01761-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Weiner DE, Sarnak MJ. Microalbuminuria: a marker of cardiovascular risk. Am J Kidney Dis. 2003;42(3):596–8. https://doi.org/10.1016/s0272-6386(03)00825-4.

    Article  PubMed  Google Scholar 

  11. Seo MH, Lee JY, Ryu S, et al. The effects of urinary albumin and hypertension on all-cause and cardiovascular disease mortality in Korea. Am J Hypertens. 2017;30(8):799–807. https://doi.org/10.1093/ajh/hpx051.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kühn A, van der Giet M, Kuhlmann MK, et al. Kidney function as risk factor and predictor of cardiovascular outcomes and mortality among older adults. Am J Kidney Dis. 2021;77(3):386–396.e381. https://doi.org/10.1053/j.ajkd.2020.09.015.

    Article  CAS  PubMed  Google Scholar 

  13. Ohkuma T, Jun M, Chalmers J, et al. Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes. Clin J Am Soc Nephrol. 2019;14(6):862–72. https://doi.org/10.2215/cjn.13391118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Haider MZ, Aslam A. Proteinuria. In: StatPearls. Treasure Island: StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.

    Google Scholar 

  15. Culleton BF, Larson MG, Parfrey PS, et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med. 2000;109(1):1–8. https://doi.org/10.1016/s0002-9343(00)00444-7.

    Article  CAS  PubMed  Google Scholar 

  16. Jensen JS, Feldt-Rasmussen B, Strandgaard S, et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35(4):898–903. https://doi.org/10.1161/01.hyp.35.4.898.

    Article  CAS  PubMed  Google Scholar 

  17. Yuyun MF, Khaw KT, Luben R, et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: the European prospective investigation into cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol. 2004;33(1):189–98. https://doi.org/10.1093/ije/dyh008.

    Article  PubMed  Google Scholar 

  18. Yuyun MF, Khaw KT, Luben R, et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am J Epidemiol. 2004;159(3):284–93. https://doi.org/10.1093/aje/kwh037.

    Article  PubMed  Google Scholar 

  19. Lees JS, Welsh CE, Celis-Morales CA, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nat Med. 2019;25(11):1753–60. https://doi.org/10.1038/s41591-019-0627-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Chang DR, Yeh HC, Ting IW, et al. The ratio and difference of urine protein-to-creatinine ratio and albumin-to-creatinine ratio facilitate risk prediction of all-cause mortality. Sci Rep. 2021;11(1):7851. https://doi.org/10.1038/s41598-021-86541-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35. https://doi.org/10.1053/j.ajkd.2014.01.416.

    Article  PubMed  Google Scholar 

  22. Romundstad S, Holmen J, Kvenild K, et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag health study (HUNT), Norway. Am J Kidney Dis. 2003;42(3):466–73. https://doi.org/10.1016/s0272-6386(03)00742-x.

    Article  PubMed  Google Scholar 

  23. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81. https://doi.org/10.1016/s0140-6736(10)60674-5.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Okubo A, Nakashima A, Doi S, et al. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function. Clin Exp Nephrol. 2020;24(5):435-443. https://doi.org/10.1007/s10157-019-01842-2.

    Article  PubMed  Google Scholar 

  25. Liu M, Wang J, Jiang B, et al. Increasing prevalence of metabolic syndrome in a Chinese elderly population: 2001-2010. PLoS One. 2013;8(6):e66233. https://doi.org/10.1371/journal.pone.0066233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Liu M, He Y, Jiang B, et al. Association between serum uric acid level and metabolic syndrome and its sex difference in a Chinese community elderly population. Int J Endocrinol. 2014;2014:754678. https://doi.org/10.1155/2014/754678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Xie X, Peng Z, Li H, et al. Association of Urine Albumin/Creatinine ratio below 30 mg/g and left ventricular hypertrophy in patients with type 2 diabetes. Biomed Res Int. 2020;2020:5240153. https://doi.org/10.1155/2020/5240153.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Su W, Wang Y, Chen K, et al. Association between nonalcoholic fatty liver and increased low-level albuminuria in postmenopausal women in China: a cross-sectional study. J Diabetes. 2021;13(6):494–505. https://doi.org/10.1111/1753-0407.13134.

    Article  CAS  PubMed  Google Scholar 

  29. Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–25. https://doi.org/10.1016/s2213-8587(15)00040-6.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Prasad RM, Tikaria R. Microalbuminuria. In: StatPearls. Treasure Island: StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.

    Google Scholar 

  31. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106(14):1777–82. https://doi.org/10.1161/01.cir.0000031732.78052.81.

    Article  CAS  PubMed  Google Scholar 

  32. Mansia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007;16(3):135–232. https://doi.org/10.1080/08037050701461084.

    Article  PubMed  Google Scholar 

  33. Redon J, Williams B. Microalbuminuria in essential hypertension: redefining the threshold. J Hypertens. 2002;20(3):353–5. https://doi.org/10.1097/00004872-200203000-00002.

    Article  CAS  PubMed  Google Scholar 

  34. de Leeuw PW, Ruilope LM, Palmer CR, et al. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch Intern Med. 2004;164(22):2459–64. https://doi.org/10.1001/archinte.164.22.2459.

    Article  PubMed  Google Scholar 

  35. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama. 2001;286(4):421–6. https://doi.org/10.1001/jama.286.4.421.

    Article  CAS  PubMed  Google Scholar 

  36. Liu CS, Pi-Sunyer FX, Li CI, et al. Albuminuria is strongly associated with arterial stiffness, especially in diabetic or hypertensive subjects--a population-based study (Taichung Community Health Study, TCHS). Atherosclerosis. 2010;211(1):315–21. https://doi.org/10.1016/j.atherosclerosis.2010.02.015.

    Article  CAS  PubMed  Google Scholar 

  37. Lin CC, Tang KT, Li CI, et al. Gender difference in the relationship of albuminuria and arterial stiffness in Chinese adults - a 6.6-year follow-up longitudinal study. Kidney Blood Press Res. 2018;43(5):1479–87. https://doi.org/10.1159/000493663.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge all the participants in this study, including the professionals who collected the data.

Funding

This study was supported by the “National Key R&D Program of China” (Funding No.2020YFC2008901), the Military Medical Youth Growth Project of PLA General Hospital (Funding No. QNC19005), and Logistics Scientific Research Project of the Chinese PLA (Funding No. 19BJZ30).

Author information

Author notes

  1. Anhang Zhang, Man Li and Jiaojiao Qiu contributed equally to this work.

Authors and Affiliations

  1. Medical School of Chinese PLA, Beijing, 100853, China

    Anhang Zhang, Man Li, Jin Sun, Yongkang Su, Shuang Cai, Qiligeer Bao & Bokai Cheng

  2. Department of Geriatrics, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China

    Anhang Zhang, Man Li, Jiaojiao Qiu, Jin Sun, Yongkang Su, Shuang Cai, Qiligeer Bao, Bokai Cheng, Shuxia Wang & Ping Zhu

  3. Department of Geriatric Cardiology, the second Medical Center, Chinese PLA General Hospital, Beijing, 100853, China

    Shouyuan Ma

  4. Department of Outpatient, the first Medical Center, Chinese PLA General Hospital, Beijing, 100853, China

    Yan Zhang

Authors
  1. Anhang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Man Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiaojiao Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yongkang Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shuang Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qiligeer Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bokai Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shouyuan Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shuxia Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ping Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Anhang Zhang and Man Li proposed the design of the study and wrote the main manuscript text. Jiaojiao Qiu, Jin Sun, Yongkang Su and Shuang Cai organize data and analyze data. Qiligeer Bao, Bokai Cheng, Shouyuan Ma and Yan Zhang prepared figures and tables. Shuxia Wang and Ping Zhu corrected the manuscript. All authors reviewed the manuscript. The author(s) read and approved the final manuscript.

Corresponding authors

Correspondence to Shuxia Wang or Ping Zhu.

Ethics declarations

Ethics approval and consent to participate

The study protocol was consistent with the ethical principles of the Helsinki Declaration and was approved by the Chinese PLA General Hospital. All participants were asked for permission to use their medical data for a non-commercial study, and written informed consent was obtained from them at the initiation of follow-up.

Consent for publication

Not applicable.

Competing interests

The authors have declared that no conflict of interest exists.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, A., Li, M., Qiu, J. et al. The relationship between urinary albumin to creatinine ratio and all-cause mortality in the elderly population in the Chinese community: a 10-year follow-up study. BMC Nephrol 23, 16 (2022). https://doi.org/10.1186/s12882-021-02644-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12882-021-02644-z

Keywords

BMC Nephrology

ISSN: 1471-2369

Contact us